Location: Home
  • search
  • go
  • Relate News
  • 2/10/2026AstraZeneca's China Business Hits New Heights as Record Revenue Boosts...
  • 2/10/2026China Biotech Lights Up. U.S. Stocks Prepare For A New Powerhouse (IBD...
  • 2/10/2026China Overhauls Drug Administration Rules, Emphasizing Quality and Cli...
  • 2/9/2026Roche and Henlius–Organon Resolve U.S. Patent Dispute Over Pertuzumab...
  • 2/9/2026J&J Wins China Approval Expanding Subcutaneous Daratumumab Use
  • 2/7/2026China Moves to Accelerate New Healthcare Insurance Models and Large‑S...
  • 2/7/2026Bio‑Thera and Avalon Forge 15‑Year Deal to Bring Keytruda Biosimilar...
  • 2/7/2026Delonix Secures IND Clearance for Novel MenB Vaccine DX-104 in China ...
  • 2/7/2026Recent Executive Moves
  • 2/6/2026China Launches Nationwide Crackdown on BMI Fraud in Mental Health Sect...
  • 2/6/2026Everest Medicines Gains Chinese Approval for VELSIPITY® in UC
  • 2/6/2026Merck's Keytruda Wins New China Approval for Frontline Endometrial Can...
  • 2/6/2026Kelun-Biotech Expands Breast Cancer Indications of sac-TMT in China
  • 2/5/2026CDE Issues Technical Guideline for Clinical Trials of Chronic Insomnia...
  • 2/5/2026Shanghai Pharma Exits BMS China, Closing a Chapter for JV Pharma in Ch...
  • 2/5/2026iMBioRay Raises Nearly CNY 200M Series B to Advance NK Cell Therapy P...
  • 2/5/2026Eisai Secures Exclusive Rights to Henlius' Anti-PD-1 Antibody Serpluli...
  • 2/5/2026Everest Medicines Licenses Micot's MT1013 for SHPT in China and Asia-P...
  • 2/5/2026Evogene and Lishan Biopharma Partner to Develop Microbiome Therapy for...
  • 2/5/2026AmCham China Hosts US FDA Delegation to Strengthen Regulatory Dialogue
  • 2/5/2026Fosun Secures Priority Review in China for Luvometinib's New Indicatio...
  • 2/5/2026Novo Nordisk Reports First Decline in Ozempic Sales in Greater China
  • 2/5/2026China Biotech Emerges as Global Deal Powerhouse, Analysts Cite Strong ...
  • 2/5/2026Global Pharma in 2025: China Remains a Key Market Amid Rising Competit...
  • 2/4/2026CMS Gets Green Light from NMPA to Launch Trials for Novel Kidney Disea...
  • 2/4/2026Bayer's Nubeqa Gains Third Approval in China for Advanced Prostate Can...
  • 2/4/2026China's Health Insurance Market Poised for $596B Surge by 2033
  • 2/4/2026Almirall's Seysara Approved in China for Moderate-to-Severe Acne
  • 2/4/2026WuXi Biologics and Sinorda Join Forces to Develop Bispecific Antibody ...
  • 2/4/2026Novartis Secures Global Rights to SciNeuro’s Next-Gen Alzheimer’s An...
  • Page:6/384 Total number of articles:11506: [First][<<] [4] [5] [6] [7] [8] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group